Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1993 2
1994 2
1995 2
1996 1
1997 1
1999 1
2002 2
2006 1
2007 1
2010 1
2012 1
2013 2
2015 2
2016 2
2018 3
2019 2
2020 1
2021 2
2022 2
2023 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study.
Zucchi E, Musazzi UM, Fedele G, Martinelli I, Gianferrari G, Simonini C, Fini N, Ghezzi A, Caputo M, Sette E, Vacchiano V, Zinno L, Anceschi P, Canali E, Vinceti M, Ferro S, Mandrioli J; ERRALS study group. Zucchi E, et al. EClinicalMedicine. 2023 Oct 5;65:102256. doi: 10.1016/j.eclinm.2023.102256. eCollection 2023 Nov. EClinicalMedicine. 2023. PMID: 37842553 Free PMC article.
The Italian multiple sclerosis register.
Trojano M, Bergamaschi R, Amato MP, Comi G, Ghezzi A, Lepore V, Marrosu MG, Mosconi P, Patti F, Ponzio M, Zaratin P, Battaglia MA; Italian Multiple Sclerosis Register Centers Group. Trojano M, et al. Neurol Sci. 2019 Jan;40(1):155-165. doi: 10.1007/s10072-018-3610-0. Epub 2018 Nov 13. Neurol Sci. 2019. PMID: 30426289 Free PMC article.
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study.
Faghri F, Brunn F, Dadu A; PARALS consortium; ERRALS consortium; Zucchi E, Martinelli I, Mazzini L, Vasta R, Canosa A, Moglia C, Calvo A, Nalls MA, Campbell RH, Mandrioli J, Traynor BJ, Chiò A. Faghri F, et al. Lancet Digit Health. 2022 May;4(5):e359-e369. doi: 10.1016/S2589-7500(21)00274-0. Epub 2022 Mar 24. Lancet Digit Health. 2022. PMID: 35341712 Free PMC article.
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression.
Tavazzi E, Daberdaku S, Zandonà A, Vasta R, Nefussy B, Lunetta C, Mora G, Mandrioli J, Grisan E, Tarlarini C, Calvo A, Moglia C, Drory V, Gotkine M, Chiò A, Di Camillo B; Piemonte, Valle d’Aosta Register for ALS (PARALS), for the Emilia Romagna Registry for ALS (ERRALS). Tavazzi E, et al. J Neurol. 2022 Jul;269(7):3858-3878. doi: 10.1007/s00415-022-11022-0. Epub 2022 Mar 10. J Neurol. 2022. PMID: 35266043 Free PMC article.
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy.
Baldin E, Zenesini C, Antonazzo IC, Bartolomei I, Caniatti L, Costa M, Curti E, Ferraro D, Foschi M, Granella F, Guareschi A, Immovilli P, Lugaresi A, Malagù S, Mancinelli L, Montepietra S, Mussuto V, Neri W, Pasquinelli M, Pellegrino L, Pesci I, Poluzzi E, Pugliatti M, Ravasio A, Riise T, Salvi F, Santangelo M, Sireci F, Sola P, Strumia S, Tsantes E, Vignatelli L, Vitetta F, Viti B, D'Alessandro R; AS_MS_Risk Group. Baldin E, et al. Among authors: malagu s. Neuroepidemiology. 2021;55(3):224-231. doi: 10.1159/000515682. Epub 2021 May 7. Neuroepidemiology. 2021. PMID: 33965951
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register.
Lepore V, Bosetti C, Santucci C, Iaffaldano P, Trojano M, Mosconi P; Italian Multiple Sclerosis Register Centers Group, the Scientific Committee of Italian SM Register. Lepore V, et al. Eur J Neurol. 2021 Feb;28(2):567-578. doi: 10.1111/ene.14589. Epub 2020 Nov 6. Eur J Neurol. 2021. PMID: 33058344
Central executive system impairment in traumatic brain injury.
Serino A, Ciaramelli E, Di Santantonio A, Malagù S, Servadei F, Làdavas E. Serino A, et al. Among authors: malagu s. Brain Inj. 2006 Jan;20(1):23-32. doi: 10.1080/02699050500309627. Brain Inj. 2006. PMID: 16403697
First-line disease-modifying drugs in relapsing-remitting multiple sclerosis: an Italian real-life multicenter study on persistence.
Ferraro D, Camera V, Baldi E, Vacchiano V, Curti E, Guareschi A, Malagù S, Montepietra S, Strumia S, Santangelo M, Caniatti L, Foschi M, Lugaresi A, Granella F, Pesci I, Motti L, Neri W, Immovilli P, Montanari E, Vitetta F, Simone AM, Sola P. Ferraro D, et al. Among authors: malagu s. Curr Med Res Opin. 2018 Oct;34(10):1803-1807. doi: 10.1080/03007995.2018.1451311. Epub 2018 Apr 12. Curr Med Res Opin. 2018. PMID: 29526118 Free article.
29 results